Showing results (51-60 of 132) with videos related to

Sort By:
Pageof 14
The Journal of Molecular Diagnostics : JMD|July 5, 2016
Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic CancerColin M Court, Jacob S Ankeny, Shonan Sho, et al.
Clinical Colorectal Cancer|November 6, 2013
Axitinib or bevacizumab plus FOLFIRI or modified FOLFOX-6 after failure of first-line therapy for metastatic colorectal cancer: a randomized phase II studyJohanna C Bendell, Christophe Tournigand, Anna Swieboda-Sadlej, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2026
The Randomized Phase 2 ARC-9 Study of Etrumadenant-Based Therapy vs Regorafenib in Patients with Previously Treated Metastatic Colorectal CancerMichael Cecchini, Sae-Won Han, Soohyeon Lee, et al.
The Oncologist|July 21, 2021
Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction AdenocarcinomaDaniel V Catenacci, Joseph Chao, Kei Muro, et al.
JCO Precision Oncology|March 21, 2025
Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 StudiesYelena Y Janjigian, Michael Cecchini, Kohei Shitara, et al.
The Lancet. Oncology|June 17, 2023
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 studyEric Van Cutsem, Maria di Bartolomeo, Elizabeth Smyth, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 22, 2021
Combination Chemo-Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti-PD-1Xiangsheng Liu, Jinhong Jiang, Yu-Pei Liao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2017
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid CancerVivek Subbiah, Robert J Kreitman, Zev A Wainberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2026
Sirexatamab in Combination with Bevacizumab and Chemotherapy as Second-Line Therapy for Advanced Colorectal Adenocarcinoma: the Phase II DeFianCe TrialZev A Wainberg, Keun-Wook Lee, Jong Gwang Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2021
A Randomized Phase II Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Patients with Advanced Gastrointestinal Stromal TumorsArun S Singh, J Randolph Hecht, Lee Rosen, et al.
Pageof 14